BioCentury | Nov 6, 2019
Company News
Biogen expanding biosimilars deal for eye therapies, anti-TNFs
As it continues to rely on biosimilars as a growth driver, Biogen has expanded its deal with Samsung Bioepis to include two new ocular biosimilars in certain major markets, as well as rights in China...